
News|Articles|December 5, 2024
System Integration: How AI Is Weaving Itself into Neurology
Author(s)Marco Meglio
Perspective from neurologists on the current and future applications for artificial intelligence across a bevy of neurologic conditions.
Advertisement
Advertisement
Artificial intelligence (AI) refers to the use of computer systems or machines to simulate human intelligence processes such as learning, reasoning, problem-solving, and decision-making. AI systems often rely on algorithms, data analysis, and machine learning to identify patterns and perform tasks that traditionally require human input. AI technologies include natural language processing, computer vision, robotics, neural networks, and machine learning, among others.
Related to this article

Asundexian lowered ischemic stroke without more major bleeding across low, intermediate, and high Framingham risk groups (all P interaction > .25).

TRANSCEND-T2D-2 topline data show retatrutide lowered A1C more and produced over twice the weight loss of semaglutide 2 mg in type 2 diabetes.

Tom Martens, MD, joins Diana Isaacs, PharmD, and Natalie Bellini, DNP, to discuss CONNECT trial data on CGM in non-insulin-treated type 2 diabetes.

Leigh Ann Pansch, MSN, FNP-BC, DCNP, discusses year-round photoprotection, missed skin cancer detection, and overlooked patients for Healthy Skin Month.

Post hoc analyses at ACAAI 2026 show 41.7% of patients-maintained CSU control and quality of life 16 weeks after stopping omalizumab.

Jasmohan Bajaj, MD, MS, joins Nancy Reau, MD, and Kimberly Brown, MD, on who to screen for HE in clinic and how to prepare patients and families.

Gerard Criner, MD, reviews GOLD 2026 sessions on mucus plugs and inhaler technique, plus multimorbidity, exacerbation risk, and the 2027 GOLD Report.
Advertisement
Advertisement

